Dergiler / European Journal of Biology / 2026 / Volume: 83 Issue: 1

In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes

Gözde Yılmaz(Istanbul University, Institute of Graduate Studies in Sciences)0000-0002-8000-2385
Sefa Çelik(ISTANBUL UNIVERSITY, FACULTY OF SCIENCE, DEPARTMENT OF PHYSICS)0000-0001-6216-1297
Ayşen Erbölükbaş Özel(ISTANBUL UNIVERSITY, FACULTY OF SCIENCE, DEPARTMENT OF PHYSICS)0000-0002-8680-8830
Sevim Akyüz(ISTANBUL KULTUR UNIVERSITY, FACULTY OF ARTS AND SCIENCES, DEPARTMENT OF PHYSICS)0000-0003-3313-6927
Sayfa
—
Yayın Tarihi
2024-05-30
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

High binding affinity against 1BNA (-6.4 kcal/mol), 6M03 (-6.3 kcal/mol), 6LU7 (-6.6 kcal/mol), and 6VXX (-6.7 kcal/mol) indicated that ERQ could be an excellent new natural therapy for the treatment of cancer and COVID-19.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Short peptides play a significant role in exploring drugs with higher selectivity and fewer side effects in cancer and COVID-19 therapies.
📊
Temel Bulgular & Veri:This study evaluated the anticancer and anti-COVID-19 activities of Glu-Arg-Gln (ERQ) tripeptide for the first time.
💡
Sonuç & Katkı:High binding affinity against 1BNA (-6.4 kcal/mol), 6M03 (-6.3 kcal/mol), 6LU7 (-6.6 kcal/mol), and 6VXX (-6.7 kcal/mol) indicated that ERQ could be an excellent new natural therapy for the treatment of cancer and COVID-19.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:In silico · Molecular docking · Glu-Arg-Gln

Abstract

Objective: Short peptides play a significant role in exploring drugs with higher selectivity and fewer side effects in cancer and COVID-19 therapies. This study evaluated the anticancer and anti-COVID-19 activities of Glu-Arg-Gln (ERQ) tripeptide for the first time. To discover the potentiality of the tripeptide as an anticancer and as a SARS-CoV-2 inhibitor, molecular docking analysis of ERQ tripeptide with DNA (PDB ID: 1BNA) and a variety of SARS-CoV-2 enzymes, namely. Main protease (PDB IDs: 6M03, 6LU7) and Spike glycoprotein (PDB ID: 6VXX) were performed. Materials and Methods: To determine the binding efficiency of ERQ to target DNA and proteins, molecular docking processes were carried out using the Autodock Vina program. The sorts of bonds and interacting residues in ERQ/DNA and ERQ/protein complexes were determined. Results: Molecular docking simulations of ERQ tripeptide against 1BNA, 6M03, 6LU7, and 6VXX were performed, and the interactions between the docked ligand and target residues were determined. The binding mechanisms of ERQ with the receptors were clarified. The binding affinities of ERQ towards the targets were predicted to be between -6.3 and -6.7 kcal/mol. ERQ showed the highest binding affinity to Spike glycoprotein (6VXX), with an estimated binding energy of -6.7 kcal/mol. Conclusion: Molecular docking simulations revealed the potential of ERQ tripeptide as an anticancer and anti-COVID-19 agent. High binding affinity against 1BNA (-6.4 kcal/mol), 6M03 (-6.3 kcal/mol), 6LU7 (-6.6 kcal/mol), and 6VXX (-6.7 kcal/mol) indicated that ERQ could be an excellent new natural therapy for the treatment of cancer and COVID-19.

🔖

Bu Makaleye Atıf Yap

Yılmaz, G., Çelik, S., Özel, A. E., Akyüz, S. (2024). In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes. European Journal of Biology, Volume: 83 Issue: 1. https://doi.org/10.26650/EurJBiol.2024.1389569

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (29)

  1. Nikfar Z, Shariatinia Z. The RGD tripeptide anticancer drug car-rier: DFT computations and molecular dynamics simulations. J Mol Liq. 2019;281:565-583. google scholar
  2. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder, JP. Synthesis of EF24-tripeptide chloromethyl ketone: A novel curcumin-related anticancer drug delivery system. J Med Chem. 2006;49(11):3153-3158. google scholar
  3. Ali H, Jabeen A, Maharjan, R, et al. Furan-conjugated tripep-tides as potent antitumor drugs. Biomolecules. 2020;10(12):1684. doi:10.3390/biom10121684 google scholar
  4. Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700-2707. google scholar
  5. Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem. 2014;57(16):6930-6948. google scholar
  6. Kumar A, Kothari J, Lokhande KB, Seethamma TN, Venkateswara Swamy K, Sharma NK. Novel antiproliferative tripeptides inhibit AP-1 transcriptional complex. Int J Pept Res Ther. 2021;27(4):2163-2182. google scholar
  7. Fan J, Fu A, Zhang L. Progress in molecular docking. Quant Biol. 2019;7(2):83-89. google scholar
  8. Pagadala NS, Syed K, Tuszynski J. Software for molecular dock-ing: A review. Biophys Rev. 2017;9(2):91-102. google scholar
  9. Gilad Y, Senderowitz H. Docking studies on DNA intercalators. J Chem Inf Model. 2014;54(1):96-107. google scholar
  10. Celik S, Vagifli F, Akyuz S, et al. Synthesis, vibrational spec-troscopic investigation, molecular docking, antibacterial and an-timicrobial studies of a new anthraquinone derivative compound. Spectrosc Lett. 2022;55(4):259-277. google scholar
  11. Protein Data Bank website. http://www.rcsb.org/pdb. Accessed November 09, 2023. google scholar
  12. Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem. 1996;17(5-6):490-519. google scholar
  13. Shao Y, Molnar LF, Jung Y, et al. Advances in methods and algorithms in a modern quantum chemistry program package. Phys Chem Chem Phys. 2006;8(27):3172-3191. google scholar
  14. Trott O, Olson AJ. Autodock vina: Improving the speed and accu-racy of docking with a new scoring function, efficient optimiza-tion, and multithreading. J Comput Chem. 2010;31:455-461. google scholar
  15. Drew HR, Wing RM, Takano T, et al. Structure of a B-DNA do-decamer: Conformation and dynamics. Proc Natl Acad Sci USA. 1981;78(4): 2179-2183. google scholar
  16. Zhao Y, Zhu Y, Liu X, et al. Structural basis for repli-case polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2. Proc Natl Acad Sci USA. 2022;119(16):e2117142119. doi:10.1073/pnas.2117142119 google scholar
  17. Jin Z, Du X, Xu Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289-293. google scholar
  18. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292. google scholar
  19. Jurcik A, Bednar D, Byska J, et al. Caver analyst 2.0: Anal-ysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories. Bioinformatics. 2018;34(20):3586-3588. google scholar
  20. Demirag AD, Çelik S, Akyuz S, Ozel A. Molecular docking anal-ysis of used drugs for the treatment of cancer. Süleyman Demirel University J Nat App Sci. 2021;25(3):539-547. google scholar
  21. Sagaama A, Brandan SA, Issa TB, Issaoui N. Searching po-tential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking. Heliyon. 2020;6(8): e04640. doi:10.1016/j.heliyon.2020.e04640 google scholar
  22. Arifa Begum SK, Begum S, Bandari P, Swapna BS, Reddemma M. Tetrandrine, an effective inhibitor of COVID-19 main protease (Mpro); Insights from molecular docking and dynamics simula-tions. Int J Pharm Investig. 2023;13(4):845-851. google scholar
  23. Celik S, Yilmaz G, Akyuz S, Ozel AE. Shedding light into the bio-logical activity of aminopterin, via molecular structural, docking, and molecular dynamics analyses. J Biomol Struct Dyn. 2023;1-22. doi:10.1080/07391102.2023.2245493 google scholar
  24. Liu X, Wang XJ. Potential inhibitors against 2019-nCoV coron-avirus M protease from clinically approved medicines. J Genet Genomics. 2020;47(2):119-121. google scholar
  25. Özdemir M, Köksoy B, Ceyhan D, Bulut M, Yalcin B. In silico, 6LU7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2. J Turk Chem Soc Sect A Chem. 2020;7(3):691-712. google scholar
  26. Hatada R, Okuwaki K, Mochizuki Y, et al. Fragment molecular orbital based interaction analyses on COVID-19 main protease-inhibitor n3 complex (PDB ID:6LU7). J Chem Inf Model. 2020;60(7):3593-3602. google scholar
  27. Celik S, Akyuz S, Ozel AE. Vibrational spectroscopic characterization and structural investigations of cepharan-thine, a natural alkaloid. J Mol Struct. 2022;1258:132693. https://doi.org/10.1016/j.molstruc.2022.132693 google scholar
  28. Holanda VN, Lima EMDA, Silva WVD, et al. Identification of 1, 2, 3-triazole-phthalimide derivatives as potential drugs against COVID-19: A virtual screening, docking and molecular dynamic study. J Biomol Struct Dyn. 2022;40(12):5462-5480. google scholar
  29. Joshi A, Sharma V, Singh J, Kaushik V. Chemi-informatic ap-proach to investigate putative pharmacoactive agents of plant ori-gin to eradicate COVID-19. Coronaviruses. 2022;3(3):40-54. google scholar